Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources

por Elzembely, Mahmoud M., Park, Julie R., Riad, Khaled F., Sayed, Heba A., Pinto, Navin, Carpenter, Paul A., Baker, K. Scott, El-Haddad, Alaa
Publicado 2018

Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk Neuroblastoma

por Balyasny, Skye, Lee, Sang Mee, Desai, Ami V., Volchenboum, Samuel L., Naranjo, Arlene, Park, Julie R., London, Wendy B., Cohn, Susan L., Applebaum, Mark A.
Publicado 2021

SIOP‐PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low‐ and middle‐income settings

por Parikh, Nehal S., Howard, Scott C., Chantada, Guillermo, Israels, Trijn, Khattab, Mohammed, Alcasabas, Patricia, Lam, Catherine G., Faulkner, Lawrence, Park, Julie R., London, Wendy B., Matthay, Katherine K.
Publicado 2015

GFAP and NfL increase during neurotoxicity from high baseline levels in pediatric CD19-CAR T-cell patients

por Gust, Juliane, Rawlings-Rhea, Stephanie D., Wilson, Ashley L., Tulberg, Niklas M., Sherman, Amber L., Seidel, Kristy D., Wu, Qian “Vicky”, Park, Julie R., Gardner, Rebecca A., Annesley, Colleen E.
Publicado 2022

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomis...

por de Alarcon, Pedro A., Matthay, Katherine K., London, Wendy B., Naranjo, Arlene, Tenney, Sheena C., Panzer, Jessica A., Hogarty, Michael D., Park, Julie R., Maris, John M., Cohn, Susan L.
Publicado 2017

Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data

por Crotty, Erin E., Wilson, Ashley L., Davidson, Tom, Tahiri, Sophia, Gust, Juliane, Griesinger, Andrea M., Venkataraman, Sujatha, Park, Julie R., Mueller, Sabine, Rood, Brian R., Hwang, Eugene I., Wang, Leo D., Vitanza, Nicholas A.
Publicado 2023

A Pilot Study of Tandem High Dose Chemotherapy with Stem Cell Rescue as Consolidation for High Risk Neuroblastoma: Children’s Oncology Group study ANBL00P1

por Seif, Alix E., Naranjo, Arlene, Baker, David L., Bunin, Nancy J., Kletzel, Morris, Kretschmar, Cynthia S., Maris, John M., McGrady, Patrick W., von Allmen, Daniel, Cohn, Susan L., London, Wendy B., Park, Julie R., Diller, Lisa R., Grupp, Stephan A.
Publicado 2013

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology...

por Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Publicado 2018

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Childr...

por Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Publicado 2018

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

por Erbe, Amy K., Wang, Wei, Reville, Patrick K., Carmichael, Lakeesha, Kim, KyungMann, Mendonca, Eneida A., Song, Yiqiang, Hank, Jacquelyn A., London, Wendy B., Naranjo, Arlene, Hong, Fangxin, Hogarty, Michael D., Maris, John M., Park, Julie R., Ozkaynak, M. F., Miller, Jeffrey S., Gilman, Andrew L., Kahl, Brad, Yu, Alice L., Sondel, Paul M.
Publicado 2017

Circulating tumor DNA reveals mechanisms of lorlatinib resistance in patients with relapsed/refractory ALK-driven neuroblastoma

por Berko, Esther R., Witek, Gabriela M., Matkar, Smita, Petrova, Zaritza O., Wu, Megan A., Smith, Courtney M., Daniels, Alex, Kalna, Joshua, Kennedy, Annie, Gostuski, Ivan, Casey, Colleen, Krytska, Kateryna, Gerelus, Mark, Pavlick, Dean, Ghazarian, Susan, Park, Julie R., Marachelian, Araz, Maris, John M., Goldsmith, Kelly C., Radhakrishnan, Ravi, Lemmon, Mark A., Mossé, Yaël P.
Publicado 2023

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a repo...

por Niemas-Teshiba, Risa, Matsuno, Ryosuke, Wang, Larry L., Tang, Xao X., Chiu, Bill, Zeki, Jasmine, Coburn, Jeannine, Ornell, Kimberly, Naranjo, Arlene, Van Ryn, Collin, London, Wendy B., Hogarty, Michael D., Gastier-Foster, Julie M., Look, A. Thomas, Park, Julie R., Maris, John M., Cohn, Susan L., Seeger, Robert C., Asgharzadeh, Shahab, Ikegaki, Naohiko, Shimada, Hiroyuki
Publicado 2017

Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety

por Vitanza, Nicholas A., Ronsley, Rebecca, Choe, Michelle, Henson, Casey, Breedt, Mandy, Barrios-Anderson, Adriel, Wein, Amy, Brown, Christopher, Beebe, Adam, Kong, Ada, Kirkey, Danielle, Lee, Brittany M., Leary, Sarah E.S., Crotty, Erin E., Hoeppner, Corrine, Holtzclaw, Susan, Wilson, Ashley L., Gustafson, Joshua A., Foster, Jessica B., Iliff, Jeffrey J., Goldstein, Hannah E., Browd, Samuel R., Lee, Amy, Ojemann, Jeffrey G., Pinto, Navin, Gust, Juliane, Gardner, Rebecca A., Jensen, Michael C., Hauptman, Jason S., Park, Julie R.
Publicado 2023

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients

por Depuydt, Pauline, Boeva, Valentina, Hocking, Toby D, Cannoodt, Robrecht, Ambros, Inge M, Ambros, Peter F, Asgharzadeh, Shahab, Attiyeh, Edward F, Combaret, Valérie, Defferrari, Raffaella, Fischer, Matthias, Hero, Barbara, Hogarty, Michael D, Irwin, Meredith S, Koster, Jan, Kreissman, Susan, Ladenstein, Ruth, Lapouble, Eve, Laureys, Geneviève, London, Wendy B, Mazzocco, Katia, Nakagawara, Akira, Noguera, Rosa, Ohira, Miki, Park, Julie R, Pötschger, Ulrike, Theissen, Jessica, Tonini, Gian Paolo, Valteau-Couanet, Dominique, Varesio, Luigi, Versteeg, Rogier, Speleman, Frank, Maris, John M, Schleiermacher, Gudrun, De Preter, Katleen
Publicado 2018

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

por Goldsmith, Kelly C., Park, Julie R., Kayser, Kimberly, Malvar, Jemily, Chi, Yueh-Yun, Groshen, Susan G., Villablanca, Judith G., Krytska, Kateryna, Lai, Lillian M., Acharya, Patricia T., Goodarzian, Fariba, Pawel, Bruce, Shimada, Hiroyuki, Ghazarian, Susan, States, Lisa, Marshall, Lynley, Chesler, Louis, Granger, Meaghan, Desai, Ami V., Mody, Rajen, Morgenstern, Daniel A., Shusterman, Suzanne, Macy, Margaret E., Pinto, Navin, Schleiermacher, Gudrun, Vo, Kieuhoa, Thurm, Holger C., Chen, Joseph, Liyanage, Marlon, Peltz, Gerson, Matthay, Katherine K., Berko, Esther R., Maris, John M., Marachelian, Araz, Mossé, Yael P.
Publicado 2023

Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a C...

por Ambros, Inge M., Tonini, Gian-Paolo, Pötschger, Ulrike, Gross, Nicole, Mosseri, Véronique, Beiske, Klaus, Berbegall, Ana P., Bénard, Jean, Bown, Nick, Caron, Huib, Combaret, Valérie, Couturier, Jerome, Defferrari, Raffaella, Delattre, Olivier, Jeison, Marta, Kogner, Per, Lunec, John, Marques, Barbara, Martinsson, Tommy, Mazzocco, Katia, Noguera, Rosa, Schleiermacher, Gudrun, Valent, Alexander, Van Roy, Nadine, Villamon, Eva, Janousek, Dasa, Pribill, Ingrid, Glogova, Evgenia, Attiyeh, Edward F., Hogarty, Michael D., Monclair, Tom F., Holmes, Keith, Valteau-Couanet, Dominique, Castel, Victoria, Tweddle, Deborah A., Park, Julie R., Cohn, Sue, Ladenstein, Ruth, Beck-Popovic, Maja, De Bernardi, Bruno, Michon, Jean, Pearson, Andrew D. J., Ambros, Peter F.
Publicado 2020

Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety

por Vitanza, Nicholas A., Wilson, Ashley L., Huang, Wenjun, Seidel, Kristy, Brown, Christopher, Gustafson, Joshua A., Yokoyama, Jason K., Johnson, Adam J., Baxter, Blake A., Koning, Ryan W., Reid, Aquene N., Meechan, Michael, Biery, Matthew C., Myers, Carrie, Rawlings-Rhea, Stephanie D., Albert, Catherine M., Browd, Samuel R., Hauptman, Jason S., Lee, Amy, Ojemann, Jeffrey G., Berens, Michael E., Dun, Matthew D., Foster, Jessica B., Crotty, Erin E., Leary, Sarah E.S., Cole, Bonnie L., Perez, Francisco A., Wright, Jason N., Orentas, Rimas J., Chour, Tony, Newell, Evan W., Whiteaker, Jeffrey R., Zhao, Lei, Paulovich, Amanda G., Pinto, Navin, Gust, Juliane, Gardner, Rebecca A., Jensen, Michael C., Park, Julie R.
Publicado 2023